Evidence map›Paper›PMID 29303844›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2018

Alcohol Use and HIV Disease Progression in an Antiretroviral Naive Cohort.

Judith A Hahn, Debbie M Cheng, Nneka I Emenyonu, Christine Lloyd-Travaglini, Robin Fatch, Starley B Shade, Christine Ngabirano, Julian Adong, Kendall Bryant, Winnie R Muyindike and 1 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Judith A HahnDivision of HIV, ID, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA.
Debbie M ChengSection of General Internal Medicine, Boston University, Boston, MA.
Nneka I EmenyonuDivision of HIV, ID, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA.
Christine Lloyd-TravagliniSection of General Internal Medicine, Boston University, Boston, MA.
Robin FatchDivision of HIV, ID, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA.
Starley B ShadeDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA.
Christine NgabiranoMbarara University of Science and Technology, Mbarara, Uganda.
Julian AdongMbarara University of Science and Technology, Mbarara, Uganda.
Kendall BryantMbarara University of Science and Technology, Mbarara, Uganda.
Winnie R MuyindikeMbarara University of Science and Technology, Mbarara, Uganda.
Jeffrey H SametSection of General Internal Medicine, Boston University, Boston, MA.
University of California, San Francisco · USBoston University · USMbarara University of Science and Technology · UGNational Institute on Alcohol Abuse and Alcoholism · US

Funding

URBAN ARCH (3/5) Uganda Cohort TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety tolerability and adherenceU01AA020776 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2011 to 2021
$4.7M
URBAN ARCH (2/5) Biostatistics and Data Management Core (BDM)U24AA020779 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CHENG, DEBBIE M. · 2011 to 2020
$3.6M
URBAN ARCH (1/5) Administrative Coordinating Core (Admin Core)U24AA020778 · NIAAA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2011 to 2020
$3.5M
Training in Research Program on Alcohol Use by Persons with our at Risk for HIVK24AA022586 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2013 to 2023
$1.8M
NIAAA NIH HHS K24 AA022586NIAAA NIH HHS U01 AA020776NIAAA NIH HHS U24 AA020778NIAAA NIH HHS U24 AA020779
6 · The paper itself

Abstract

backgroundAlcohol use has been shown to accelerate disease progression in experimental studies of simian immunodeficiency virus in macaques, but the results in observational studies of HIV have been conflicting.

methodsWe conducted a prospective cohort study of the impact of unhealthy alcohol use on CD4 cell count among HIV-infected persons in southwestern Uganda not yet eligible for antiretroviral treatment (ART). Unhealthy alcohol consumption was 3-month Alcohol Use Disorders Identification Test-Consumption positive (≥3 for women, ≥4 for men) and/or phosphatidylethanol (PEth-an alcohol biomarker) ≥50 ng/mL, modeled as a time-dependent variable in a linear mixed effects model of CD4 count.

resultsAt baseline, 43% of the 446 participants were drinking at unhealthy levels and the median CD4 cell count was 550 cells/mm (interquartile range 416-685). The estimated CD4 cell count decline per year was -14.5 cells/mm (95% confidence interval: -38.6 to 9.5) for unhealthy drinking vs. -24.0 cells/mm (95% confidence interval: -43.6 to -4.5) for refraining from unhealthy drinking, with no significant difference in decline by unhealthy alcohol use (P value 0.54), adjusting for age, sex, religion, time since HIV diagnosis, and HIV viral load. Additional analyses exploring alternative alcohol measures, participant subgroups, and time-dependent confounding yielded similar findings.

conclusionUnhealthy alcohol use had no apparent impact on the short-term rate of CD4 count decline among HIV-infected ART naive individuals in Uganda, using biological markers to augment self-report and examining disease progression before ART initiation to avoid unmeasured confounding because of misclassification of ART adherence.

Indexed as

Disease ProgressionAdolescentAdultAgedAged, 80 and overAlcoholismCD4 Lymphocyte CountFemaleGlycerophospholipidsHIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesUgandaGlycerophospholipidsphosphatidylethanol

Identifiers

PMID29303844
PMCPMC5844835
OpenAlexW2782371488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.